⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Biotronik and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Biotronik
↗Berlin, Germany
Biotronik is a leading multinational medical device company headquartered in Berlin, Germany, specializing in the development of innovative therapies and technologies for cardiovascular and endovascular diseases. The company is a pioneer in cardiac rhythm management (CRM), electrophysiology, and vascular intervention, and has recently expanded into the neuromodulation market.
For over 60 years, Biotronik has focused on engineering trusted, life-changing therapies, including pacemakers, implantable defibrillators, and remote patient monitoring systems. The company is known for its commitment to quality and innovation, producing critical components in-house and maintaining a global presence with research, development, and manufacturing operations across Europe, North America, and Singapore.
CLASSIFICATION
Company Type:MedTech
Therapeutic Areas:-
Industry:Medical Devices
Sub-Industry:Cardiac Rhythm Management, Electrophysiology, Neuromodulation
SIZE & FINANCIALS
Employees:5001-10000
Founded:1963
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A
Modalities:Active Implantable Devices, Digital Health, Remote Patient Monitoring
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Kenkou
Key Partnerships:Egg Medical (Radiation protection)
COMPETITION
Position:Leader
Competitors:Medtronic, Boston Scientific, Abbott
LEADERSHIP
Scientific Founders:Max Schaldach, Otto Franke
LINKS
Website:biotronik.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Biotronik. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.